Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

Posted on: 15 May 18

VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FRANKFURT:ZSB), announces an extension to the term of 2,073,750 common share purchase warrants (the “Warrants”) originally issued on May 11, 2016. The warrants were issued as part of a private placement. The expiry dates will be extended as follows: 

May 11 , 2016 
Number of Warrants: 2,073,750
Original Expiry Date of Warrants:May 11, 2018
New Expiry Date of Warrants:May 11, 2019
Exercise Price of Warrants:$0.30

All other terms of the Warrants will remain unchanged.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information regarding this press release, please contact:

Christopher Hopton, CFO
Sirona Biochem Corp.
Phone:  1.604.282.6064


Last updated on: 15/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.